Respicardia Announces Highmark Coverage for the remedē® System in Patients with Central Sleep Apnea
MINNETONKA, Minn., Jan. 7, 2021 /PRNewswire/ -- Respicardia, Inc., the manufacturer of the only FDA-approved active implantable system for the treatment...